Abstract The global gene expression in three types of canine mammary tumors: carcinoma, fibrosarcoma and osteosarcoma were investigated by Affymetrix gene array technology. Unsupervised clustering analysis revealed a close clustering of the respective tumor types, with fibrosarcomas clustering close to the osteosarcomas and the carcinomas clustering closer to non-malignant mammary tissues (NMTs). A number of epithelial markers were expressed in both carcinomas and NMTs, whereas the sarcomas expressed genes related to mesenchymal differentiation. A comparison of the gene expression profile of the sarcomas versus carcinoma/NMTs revealed that the sarcomas, in particular the osteosarcomas, showed a striking upregulation of a panel of homeobox genes previously linked to craniofacial bone formation. In line with this finding, osteosarcomas showed an upregulation of bone morphogenetic proteins (BMPs) and of genes associated with retinoic acid signaling. Increased homeobox gene expression in sarcomas was also confirmed at the protein level by immunohistochemical analysis of tumor tissue, and in an osteosarcoma cell line after stimulation by BMP-2. These findings suggest that the development of mammary sarcomas specifically involves triggering of a set of homeobox genes related to neural crest and craniofacial bone development.
lymphatic system and most sarcomas metastasizing directly via the blood vascular system [2, 5, 6] .
In female dogs, spontaneous mammary tumors including sarcomas constitute the most common form of malignancy [7] . Overall, canine and human cancers have similar biological characteristics, such as the role of steroidal hormones in tumorigenesis, the correlation between grade of histological malignancy and rate of metastasis, and the organ-related pattern of metastasis [1, 8] . For mammary carcinomas the shift towards steroidal autonomy-based upon the lack of estrogen and progestin receptors and absence of response to antihormonal treatment, appears to be more common in the dog than in the human [7] , while a near complete lack of data exists on this issue in sarcomas. Mammary sarcomas, on the other hand, appear to be relatively more common in the dog as compared to the human. Thus, material for studying the disease is more readily available from canine than from human sources and investigations of canine sarcoma could provide useful comparative oncological insight that may be valuable for understanding the pathology also of human sarcomas. For example, dogs are relatively outbred based on single nucleotide polymorphism frequency and the background gene diversity between dog breeds is comparable with that in humans [9, 10] . Further, inter-species comparisons of a number of genes involved in tumor development (P53, MET, IGFIR, KIT and mTOR) have shown that the human and canine genes are more closely related to each other than the corresponding human and mouse genes [9, 11, 12] . Another major advantage of using the canine system as model is that the studied tumors occur spontaneously, in contrast to the experimentally induced tumors in various murine model systems.
Microarray technology has proven to be a powerful tool in classifying natural subtypes of breast cancer [13, 14] . Much effort has been put into finding a ''minimal set of genes'' to identify subclasses of tumors and there are examples of identified gene sets that have been successful in predicting outcome of disease [15] [16] [17] [18] . So far, to our knowledge, there have been no mammary/breast sarcomas subjected to gene expression profiling, although soft tissue and osteosarcomas from other organ systems have been studied. Among the dysregulated genes in sarcomas are tyrosine kinases and transcription factors such as homeobox transcription factors normally involved in development [19, 20] .
Homeobox transcription factors have well documented roles in embryo development, where they control embryo patterning and cell differentiation. A growing body of evidence indicates a connection between dysregulated homeobox genes with disease and congenital abnormalities [21] . Expression of several homeobox genes, for example MSX-2, has been identified during the development of the mammary gland [22, 23] where they are candidates for the orchestration of the cell signaling that enables the gland to undergo repeated cycles of growth and functional differentiation [24] . Homeobox genes are also known to be upregulated in tumors, where they have been linked to differentiation and prognosis [24] [25] [26] [27] .
Here we used gene array technology to compare the global gene expression patterns in canine mammary simple carcinomas, fibrosarcomas and osteosarcomas. The canine genome has only recently been made available [10] and this is the first study where global gene expression is studied in primary canine mammary tumors. Our results reveal profound differences in the gene expression patterns of the various canine mammary tumors, and we provide evidence for a specific upregulation of homeobox genes in mammary sarcomas. Homeobox genes are currently receiving much attention for their potential role in metastasis [28] [29] [30] . Our results thus provide new insight into the expression of homeobox genes in mammary malignancies, and suggest that homeobox gene expression is a hallmark of mammary sarcoma/osteosarcoma.
Materials and methods

Tumor and control specimens
Primary canine mammary tumors, osteosarcomas (n = 5), fibrosarcomas (n = 6), simple carcinomas (n = 7) and normal mammary tissue controls (n = 4) were obtained from patients subjected to surgery, snap frozen in liquid nitrogen and stored in -80°C. See Table 1 for further information and classification of the tumors.
RNA preparation
RNA was prepared from tumor specimens by pulverizing 250 mg of the tumor under liquid nitrogen in a mortar followed by addition of 6 ml Trizol (Invitrogen). The RNA quality was evaluated with the Agilent 2100 Bioanalyzer system. RNA was purified on Qiagen mini columns and RNA concentration measured with a NanoDrop ND-1000 spectrophotometer.
Microarray expression analysis
From each sample of total RNA, 2 lg were used to prepare biotinylated fragmented cDNA according to the GeneChip Ò Expression Analysis Technical Manual (Rev. 5, Affymetrix Inc., Santa Clara, CA). Affymetrix GeneChip Ò expression arrays (Canine Genome 2.0 Array) were hybridized for 16 h in a 45°C incubator, rotated at 60 rpm. The arrays were then washed and stained using the Fluidics Station 450 and finally scanned using the GeneChip Ò Scanner 3000 7G.
Microarray data analysis
Analysis of the gene expression data was carried out in the statistical computing language R (http://www.r-project. org) using packages available from the Bioconductor project (www.bioconductor.org). The raw data were normalized using the robust multi-array average (RMA) [31] background-adjusted, normalized and log-transformed summarized values. In order to search for the differentially expressed genes, an empirical Bayes moderated t-test was applied [32] . To address the problem with multiple testing, the P values were adjusted according to Benjamini and Hochberg [33] . The gene clusterings were performed with the program Genesis, version 1.7.1 [34] .
Immunohistochemistry
Tissues were fixed in 4% buffered formalin and sections were baked in 37°C, overnight followed by 1 h in 60°C. Heat induced antigen retrieval in decloaking chamber (Biocare Medical) and PT Module Buffer 1 (1009 citrate buffer pH 6.0) was performed (Labvision). Slides were washed in TBS with 0.3% Tween-20. Polyclonal affinity purified antibodies against MSX2 (HPA005652), SIP1/ ZEB2 (HPA003456) and SatB2 (HPA001042) generated within the Swedish Human protein atlas project (HPA) www.proteinatlas.org were used [35] . The antibodies were generated using an antibody-based proteomics approach [36] . For detection, the ABC-Elite system (Vector laboratories, CA, USA) and DAB were used. For every immunohistochemical analysis, a negative control was used in addition to canine mammary gland and human tissue arrays as positive controls for the antibodies.
BMP cell stimulation
The mammary osteosarcoma cell line 353H1A clone 1 was stimulated with BMP-2. Cells were incubated overnight in RPMI 1640 with 0.5% fetal bovine serum. Cells were stimulated with 250 ng/ml BMP-2 (Peprotech, London, UK) in PBS/1.3% bovine serum albumin (BSA) for 1 h (37°C). Negative controls were incubated with PBS/1.3% BSA. The cells were trypsinized and cytospin slides were prepared. Immunofluorescence with stimulated cells Mammary osteosarcoma cells were fixed with 4% buffered formalin and antigen retrieval performed. The cells were blocked with 1% horse serum/1% donkey serum in TBS with 0.05% Tween-20 and then incubated with the polyclonal primary antibodies diluted in the blocking solution (P-Smad 1/5 [37] ), SIP1/ZEB2 (HPA003456) and Goosecoid (Santa Cruz). The primary antibodies were detected by a Cy3-labeled donkey anti-rabbit antibody (Jackson ImmunoResearch). The slides were mounted with Vectashield (Vector laboratories) and imaged with an epifluorescence microscope (Axioplan II, Zeiss).
Results and discussion
This is the first study that addresses the gene expression profiles of various canine mammary tumor types. We used the Affymetrix Canine Genome 2.0 expression array to compare the global gene expression patterns of canine mammary simple carcinomas, osteosarcomas and fibrosarcomas (see Table 1 for classification of the used tumors). As a control, non-malignant mammary tissue (NMT) was used. An unsupervised clustering of the gene expression data showed that the different tissues clustered well together in the four separate groups (Fig. 1) . As expected, the osteosarcoma and fibrosarcoma groups showed an adjacent clustering. The carcinomas and NMTs clustered closely, in line with predominant epithelial gene expression of both tissues. Since the canine genome has not yet been fully annotated with gene ontology terms, a detailed gene ontology analysis of the data is not possible at this stage. In order to analyze differences in the gene expression patterns of the different types of tumors, we performed a supervised analysis with the two sarcoma groups, osteosarcomas and fibrosarcomas versus the simple carcinomas (suppl. Fig. 1 ). Overall, genes related to extracellular matrix and mesenchymal genes dominated in the sarcomas whereas characteristic epithelial genes dominated in the carcinomas. For example, several genes involved in cellcell adhesion and genes related with epithelial differentiation were expressed at higher levels in the carcinomas than in sarcomas, e.g., various cytokeratins, E-cadherins and occludin (suppl. Fig. 1 , suppl. Table 1 ). The carcinomas and the NMT showed similar expression patterns, e.g., expressing several genes associated with epithelial morphology and cell-cell adhesion (suppl. Fig. 1, suppl . Table 1 ).
In Table 2 , the 21 genes that showed the highest upregulation in sarcomas versus carcinomas are displayed. These include a number of connective tissue-related genes, e.g., procollagen type V, matrix metalloprotease 16, collagen-binding protein 2 and procollagen C-endopeptidase enhancer. Further, an upregulation of leprecan, a proteoglycan found in basement membranes, was seen and there was also an upregulation of sarcoglycan, the latter being a transmembrane glycoprotein found predominantly in muscle tissue. We also note that Elastin microfibril interfacer, a gene associated with focal adhesion, was highly expressed and that genes characteristic for mesenchymal morphology were expressed: FK506 binding protein precursor, Microtubule-associated protein 1A and Discoidin domain receptor tyrosine kinase 2, the latter being implicated in chondrocyte proliferation. Further, sarcomas expressed high levels of cysteine dioxygenase, an enzyme involved in Cys metabolism and that has been linked to neurological disorders. Interestingly, pleiotrophin, an angiogenic factor that has been implicated in the angiogenic switch in different cancer models in vivo [38] , was significantly higher expressed in the sarcomas than in carcinomas. Sarcomas also expressed high levels of reticulocalbin 3, an ER resident Ca 2? -binding protein, as well as olfactomedin-like protein 3, glutathione S-transferase theta 2, ubiquitin carboxyterminal hydrolase L1, serine (or cysteine) proteinase inhibitor clade H member 1 and aldehyde dehydrogenase.
A number of transcription factors were highly expressed in the sarcomas: early B-cell factor (EBF1), transcription factor COE1, zinc finger CCHC domain containing 12 and two homeobox transcription factors: Paired mesoderm homeobox 1 isoform (PMX-1b) and SIP1/ZEB2. Moreover, when comparing the expression profile of osteosarcomas versus carcinomas, additional homeobox factors were found among the genes showing the highest degree of upregulation, e.g., homeobox protein DLX-5, homeobox A4, paired mesoderm homeobox protein 2 and Short stature homeobox 2. Taken together, the individual tumor types thus express high levels of a number of genes characteristic of the respective tissue, indicating a good correlation between gene expression profile and histological classification.
Considering the potential involvement of homeobox genes in differentiation and in malignancy, we decided to further investigate the homeobox gene expression in the various mammary tumors. Another reason for addressing the homeobox gene expression is that they can act as master genes, i.e., regulating a number of additional genes [28] . A supervised clustering of this group of genes indeed revealed a striking upregulation of a large number of homeobox genes in the sarcomas, especially in the osteosarcomas, when compared to the expression levels in the carcinomas (Fig. 2) . For example, SIP1/ZEB2, paired related homeobox 1 and paired like transcription factor 2 isoform C were upregulated in both osteo and fibrosarcomas. Further, MSX-2, special AT-rich sequence-binding protein 2 (SatB2), Goosecoid, DLX-5 and DLX-6, all belonging to the homeobox gene family, were markedly upregulated in osteosarcomas as opposed to NMT/carcinomas. Interestingly, two of the simple carcinomas, 203B and P208, clustered together with the sarcomas in terms of homeobox gene expression (Fig. 2) . For example, 203B showed expression of the homeobox genes DLX-5, DLX-6 and hox A5, whereas P208 expressed Paired related homeobox 1 and MSX-2. These findings indicate a distinct phenotype of 203B and P208 in comparison with the remaining carcinomas. This is also supported by lower expression of the luminal cytokeratins 7, 8 and 18 in the P208 tumor as compared with the other carcinomas (suppl. Fig. 1 ). Together with expression of cytokeratin 5, a basal cell marker, these results indicate that the P208 tumor may constitute a basal cell carcinoma and this notion is also supported by morphological criteria (see Fig. 3i ). The 203B carcinoma differed from the other carcinomas in being lipid-rich (Table 1) . Possibly, the different homeobox gene expression profile of this carcinoma might be related to this feature.
Next, we used immunohistochemistry to confirm the upregulated homeobox expression at the protein level, by analyzing three different homeobox transcription factors: SIP1/ZEB2, MSX-2 and SatB2. Overall, the immunohistochemical analysis correlated well with the gene expression data, showing a higher percentage of homeobox-positive cells in the sarcomas, in particular the osteosarcomas, than in carcinomas (Fig. 3, Table 3 ). Further, the homeobox transcription factor staining intensity was generally higher in the osteosarcomas than in the carcinomas. The fibrosarcomas showed strong staining for SIP1/ZEB2, in agreement with the high mRNA levels in the fibrosarcomas (Fig. 2) and, moreover, the weak staining for SatB2 in the fibrosarcomas is in line with the low SatB2 mRNA levels. SatB2 staining was predominantly seen in undifferentiated cells in the osteosarcomas, whereas the more differentiated cells showed lower expression (Fig. 3c) . This is well in line with the reported expression of SatB2 in undifferentiated cells from calvarial sutures [39] . Only two out of six studied fibrosarcomas were positive for MSX-2 (Table 3) , in good agreement with the relatively low levels of MSX-2 mRNA in fibrosarcomas (Fig. 2) . Although the majority of the carcinomas were negative or only weakly positive for MSX-2 protein, one of the carcinomas (P208) was positive (Fig. 3i) , with the latter being well in agreement with the mRNA expression profile (Fig. 2) . It should also be emphasized that the carcinomas, despite low SIP1/ZEB2 mRNA expression (see Fig. 2 ), showed positive staining for SIP1/ZEB2, although the number of positive cells and the intensity of staining was much lower than in the osteosarcomas (Fig. 3, Table 3 ). Taken together, the immunohistochemistry data thus support an upregulation of homeobox expression in sarcomas, particularly in osteosarcomas.
Retinoic acid is well known to regulate homeobox genes in development [40, 41] . In addition, bone morphogenetic proteins (BMPs) are known to upregulate homeobox gene expression and are also implicated in other aspects of homeobox transcription factor function [22, [42] [43] [44] . Hence, we can hypothesize that upregulated homeobox gene expression in the sarcomas may be accompanied by expression of genes related to BMP and retinoic acid signaling. Next, we investigated this hypothesis. Indeed, expression of several BMPs, BMP-1, -2, -4, -5 and -6, was evident in the osteosarcomas. For example, BMP-1 was expressed in the majority of the osteo and fibrosarcomas and expression of BMP-2 and BMP-5 were seen in several of the fibrosarcomas as well as in the carcinomas P208 and P225 (Fig. 4a) . Further, BMPs were among the genes that Fig. 2 Clustering of homeobox genes, in total 206 genes. Genes with visible change of expression are shown. Genes used for verification with immunohistochemistry (see Fig. 3 and Table 3 ) are marked with asterisks showed the highest extent of upregulation when comparing the global gene expression pattern of osteosarcomas with that of both carcinomas and NMT (data not shown). It was also evident that a number of genes related to retinoic acid signaling, e.g., retinoic acid receptor beta (RAR-beta) and Retinoic acid receptor responder 1 isoform 1, were upregulated in osteosarcomas (Fig. 4b) . Noteworthy, the latter genes were also highly expressed in two of the carcinomas, 346B and P208. Moreover, retinoic acid binding protein 1 was highly expressed in the fibrosarcomas (Fig. 4b) .
The presented results implicate increased homeobox transcription factor expression in mammary osteosarcomas. Next, we studied the homeobox protein expression and subcellular localization in response to growth factor stimulation. An osteosarcoma cell line (derived from the primary osteosarcoma 353H1A included in this study) was stimulated by BMP-2, a growth factor fundamental for development and bone formation [45] . BMPs are known to activate the Smad pathway, leading to Smad phosphorylation [46] , and previous studies have shown that Smad proteins can interact with the homeobox transcription factor SIP1/ZEB2 [47] . We therefore studied Smad and homeobox protein expression and cellular localization in response to BMP stimulation. As shown in Fig. 5 , nonstimulated cells were only weakly positive for phosphorylated Smad 1/5, (Fig. 5a) . However, upon stimulation with BMP-2, a markedly increased staining for phosphorylated Smad 1/5 was seen and, interestingly, the staining was predominantly localized to the nucleus (Fig 5b) . Non-stimulated cells were also positive for SIP1/ZEB2, being located in the nucleus (Fig. 5c) . However, upon BMP-2 stimulation, an increased nuclear staining for SIP1/ ZEB2 was seen, together with the appearance of SIP1/ ZEB2 staining in the cytoplasm and the plasma membrane (Fig. 5d) . Thus, BMP stimulation leads to increased SIP1/ ZEB2 protein expression accompanied by an altered cellular localization, implicating SIP1/ZEB2 in the BMP signal transduction pathway in this osteosarcoma cell line. The osteosarcoma cell line was also positive for Goosecoid, another homeobox transcription factor, in agreement with the high levels of Goosecoid mRNA seen in the various osteosarcomas (Fig. 2) . Goosecoid staining was predominantly seen in the nucleus (Fig. 5e, f) and was not increased upon BMP-2 stimulation, indicating constitutive expression.
It is striking to note that the majority of the homeobox genes that were upregulated in the osteosarcomas are known to be involved in craniofacial bone development (suppl. Table 2 ), e.g., Goosecoid [48] , SatB2 [21] , MSX1 and MSX2 [49, 50] , DLX5 and DLX6 [51] , paired related homeobox 1 [52] and SIP1/ZEB2 [53] . The cells forming the craniofacial bone are neural crest-derived [44, 54] and it is worth noting that neural crest genes have been found to be upregulated in synovial sarcomas [55, 56] . Interestingly, the same homeobox and BMP genes (MSX2, Iroquois homeobox protein 5, BMP-2 and -7) together with retinoic acid signaling genes identified in synovial sarcomas [55] , were also expressed in the sarcomas used in this study. Induction of neural crest genes typically involves signaling through the retinoic acid pathway and the latter is crucial for migrating neural cells in development. The osteosarcomas were found to express genes involved in retinoic acid signaling (Fig 4b) as well as an upregulation of growth factors of the BMP family (Fig. 4a) , well in line with the known involvement of BMPs in bone formation as well as with the connection between BMPs and retinoic acid signaling seen in neural crest development. In fact, the significant expression of genes involved in craniofacial bone and neural crest development can explain why we see a number of neural genes expressed, e.g., Microtubuleassociated protein 1A and transcription factor COE1, which are involved in dendritic branching and development of medium spiny neurons, respectively (see suppl. Fig 1  and Table 2 ). It is also noteworthy that the sarcomas expressed tooth markers (dentin sialophosphoprotein, amelogenin), and glial (meteorin) genes (data not shown). Taken together, we may thus suggest that the development of sarcoma specifically involves triggering of a set of homeobox genes related to neural crest and craniofacial bone development.
